Our Team

Board Members

  • Chairman
  • MD from Katholieke Universiteit Leuven
  • Ph.D. in Physiology from the Univ. of Louisville
  • CEO of Apellis Pharmaceuticals (Nasdaq: APLS)
Dr. Cedric Francois
Dr. Cedric Francois
  • Board Member
  • M.Sc., MBA
  • NASDAQ: DYN
John Cox
John Cox
  • Board Member
  • Ph.D. in Molecular and Cellular Biology, Stony Brook Univ.
  • Life Sciences Team Member, Morningside Venture
Dr. Westley Nolin
Dr. Westley Nolin
  • Founder, CEO & Board Member
  • MD studies, Technion
  • Ph.D. in Molecular Immunology, Technion
  • Co-founder and CSO, Navina.ai
  • Co-founder, CTO and Board Member, MeMed
Dr. Kfir Oved
Dr. Kfir Oved
  • Board Member
  • L.L.B.
  • Managing Partner, TLV Partners
Shahar Tzafrir
Shahar Tzafrir
Previous
Next

Executive Team

  • Vice President, Discovery
  • Ph.D. in Immunology, Technion
  • NASDAQ: ACET
Dr. Galit Denkberg
Dr. Galit Denkberg
  • Vice President, CMC
  • Ph.D. in Molecular Biology, Weizmann Institute of Science
  • NASDAQ: TEVA, Ferring Pharmaceuticals
Dr. Sharon Reef
Dr. Sharon Reef
  • Director of Immunology
  • Ph.D. in Immunology, Technion
Dr. Inbar Arman
Dr. Inbar Arman
  • IP manager
  • Patent Attorney
  • TEVA, ACET, MeMed Diagnostics
Sharon Oz
Sharon Oz
  • Founder, CEO & Board Member
  • MD studies, Technion
  • Ph.D. in Molecular Immunology, Technion
  • Co-founder and CSO, Navina.ai
  • Co-founder, CTO and Board Member, MeMed
Dr. Kfir Oved
Dr. Kfir Oved
  • Vice President, Clinical Development & Medical Affairs
  • MD, Tel Aviv University
  • PhD in immunology, Weizmann Institute of Science
  • NASDAQ: GMDA
Dr. Roei Mazor
Dr. Roei Mazor
Previous
Next

Clinical Advisory

  • MD, Prof. of Neurology at George Washington Univ.
  • Principle Investigator Myasthenia Gravis Rare Disease Network, MGNet.
  • 180 publications, 40 book chapters.
Prof. Henry Kaminski
Prof. Henry Kaminski
  • Prof. Marc de Baets MD, PhD.
  • Prof. neuroimmunology at the Univ. of Maastricht dept neurosciences.
  • Consulting physician at the Maastricht University Hospital MUMC.
  • 171 publications.
Prof. Marc de Baets
Prof. Marc de Baets
  • MD/Ph.D., Prof. of Neurology at the Univ. of Miami.
  • Chief of the Neuromuscular Division, Walter Bradley Chair in ALS Research, and Executive Director of the ALS Center.
Prof. Michael Benatar
Prof. Michael Benatar
  • Neurology Chair at the Univ. of Buffalo, holds the Irvin & Rosemary Smith Chair.
  • Expert in neuromuscular disorders, myasthenia gravis, and peripheral neuropathies.
  • SUNY Distinguished Professor and has published extensively in his field.
  • 158 publications, 26 book chapters.
Prof. Gil I. Wolfe
Prof. Gil I. Wolfe
Previous
Next

Scientific Advisory

  • R&D ADC Advisor, former CSO at ImmunoGen
  • Honorary Professor, The Queen’s Univ., Belfast, UK
  • World Class ADC Expert
Dr. John M. Lambert
Dr. John M. Lambert
  • Senior CMC Advisor
  • Manager and Principal Consultant at JT Consulting, LLC.
Dr. Jorg Thommes
Dr. Jorg Thommes
  • Senior Regulatory Advisor
  • Founder and Principal Consultant at RegPath LLC
Dr. Amy Jennings
Dr. Amy Jennings
  • ADC Advisor, worked for Merck, J&J, Medimmune & AZN, Bionavigen.
  • NASDAQ: MRK, AZN, JNJ
  • Expert in ADC Preclinical, CMC, Translational, Clinical, and Regulatory
Dr. Rakesh Dixit
Dr. Rakesh Dixit
Previous
Next